Ten23 Announces Major Expansion in Swissfillon Site in Switzerland

Ten23 Health, a Contract Development and Manufacturing Organisation (CDMO) announced the expansion of the Swissfillon manufacturing unit in Visp, Switzerland, which it acquired in Oct 2021.

The  Swissmedic and FDA-inspected Visp facility now provides sterile production of pre-filled syringes, cartridges, and vials for clinical trials and market supplies. 

The most recent development is the construction of a new production house dedicated entirely to Ten23 Health in Visp-West, with approximately 5,000 square metres of space spread across four floors.

It can house 3 additional manufacturing lines, as well as technical areas, offices, and laboratories. The building's superstructure will be finished in the summer of 2022.